Lataa...
Rapamycin by Itself and Additively in Combination with Carboplatin Inhibits the Growth of Ovarian Cancer Cells
OBJECTIVE: The current standard treatment for ovarian carcinoma, consisting of surgery followed by chemotherapy with carboplatin and paclitaxel, is fraught with a high rate of recurrences. We hypothesized that targeted inhibition of specific signaling pathways in combination with conventional drugs...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2725429/ https://ncbi.nlm.nih.gov/pubmed/19576622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2009.06.002 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|